ISBInsight

Beyond the exotic: Branding India

Beyond the exotic: Branding India

Building superior digital user engagement: The sports opportunity

Building superior digital user engagement: The sports opportunity

Do consumers put their money where their mouth is?

Do consumers put their money where their mouth is?

Category management: The art of allocating shelf space

Category management: The art of allocating shelf space

Why the gender gap persists in Indian workplaces

Why the gender gap persists in Indian workplaces

  • FMCG Lessons for Pharma

    FMCG Lessons for Pharma

    What were the key success factors for Arogya Parivar, a bottom-of-the-pyramid initiative by Swiss pharmaceutical major Novartis? In this article, Meenakshee Sinha and Professor S. Arunachalam present a replicable fast-moving consumer good blueprint for rural marketing based on the Arogya Parivar experience.

  • The lesser evil? Evaluating e-cigarette consumption

    The lesser evil? Evaluating e-cigarette consumption

    While cigarette smoking is on the wane, 'vaping' is on the rise worldwide. Do e-cigarettes really help smokers kick the nicotine habit? And what may be the best public policy options for regulating their use? Research by Professor Vithala R. Rao and Dr Jialie Chen offers some answers.

  • Digital health start-ups in India: The challenge of scale

    Digital health start-ups in India: The challenge of scale

    Digital health start-ups are bringing novel technologies such as wearable tech, telemedicine, genomics and artificial intelligence to the Indian healthcare system. Hanu Tyagi surveys the start-up landscape and offers pointers for the challenge of scaling up

  • Rx ICT: Digitally disrupting healthcare

    Rx ICT: Digitally disrupting healthcare

    Technology can be a game-changer in addressing the endemic problems that affect the Indian healthcare ecosystem. However, digital disruption needs careful identification of the right problems to solve

  • Kirana stores are here to stay": FMCG strategy for Indian retail

    Kirana stores are here to stay": FMCG strategy for Indian retail

    How is the retail industry in emerging markets different from developed economies? Professor Siddharth Singh discusses insights from a recent analysis of FMCG marketing in India.

  • What do non-compete agreements cost CEOs?

    What do non-compete agreements cost CEOs?

    One of the important effects of non-competes is that this potential for harm is alleviated, which can make firms more willing to fire non-performing CEOs

  • Are CEO appointments in India caste/religion biased?

    Are CEO appointments in India caste/religion biased?

    Do top Indian companies hire professional Chief Executive Officers on the basis of caste or religion? And does it matter for financial performance? Professors Naga Lakshmi Damaraju and her co-author Anil K Makhija offer some surprising insights on these important questions

  • Why stock prices tumble after bank CEO turnover

    Why stock prices tumble after bank CEO turnover

    Government owned banks are particularly impacted by the ongoing non-performing assets (NPA) problem. They are thus more prone to transitional effects like higher loan loss provisioning or deliberate slower growth

  • Can trade save forests?

    Can trade save forests?

    Export-oriented manufacturing and service activity as well as foreign direct investment, are the surprising ingredients of an economic trajectory that promotes forest growth in developing economies, Professor Ashwini Chhatre and his colleagues find

  • Can mutual fund competition drive returns?

    Can mutual fund competition drive returns?

    Though mutual funds are increasingly popular as investment vehicles, the factors that drive their returns are not fully understood. How can investors better understand how well a fund has done relative to its competition? Research by Professors Nitin Kumar, Gerard Hoberg and Nagpurnanand Prabhala answers these questions

  • The side effects of drug price controls

    The side effects of drug price controls

    The 2013 Drug Price Control Order capped prices of over 300 drugs in the Indian market. Using an experimental design to assess the consequences of this price control on the anti-diabetic drug Metformin, Professor Chirantan Chatterjee and his co-authors show the unintended consequences of such price regulation